Mauro Zaccarelli

2.8k total citations
91 papers, 1.7k citations indexed

About

Mauro Zaccarelli is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mauro Zaccarelli has authored 91 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Infectious Diseases, 54 papers in Virology and 31 papers in Epidemiology. Recurrent topics in Mauro Zaccarelli's work include HIV Research and Treatment (54 papers), HIV/AIDS drug development and treatment (51 papers) and HIV/AIDS Research and Interventions (46 papers). Mauro Zaccarelli is often cited by papers focused on HIV Research and Treatment (54 papers), HIV/AIDS drug development and treatment (51 papers) and HIV/AIDS Research and Interventions (46 papers). Mauro Zaccarelli collaborates with scholars based in Italy, United States and United Kingdom. Mauro Zaccarelli's co-authors include Andrea Antinori, Maria Paola Trotta, Carlo Federico Perno, Adriana Ammassari, Valerio Tozzi, Federica Forbici, Pasquale Narciso, Patrizia Lorenzini, Giuseppe Ippolito and Enrico Girardi and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Mauro Zaccarelli

91 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mauro Zaccarelli Italy 25 1.2k 953 498 218 162 91 1.7k
Antonio Ocampo Spain 22 1.0k 0.8× 587 0.6× 704 1.4× 223 1.0× 336 2.1× 86 1.8k
Vadim Pokrovsky Russia 16 1.0k 0.8× 872 0.9× 563 1.1× 190 0.9× 144 0.9× 53 1.4k
Nagalingeswaran Kumarasamy India 25 1.3k 1.1× 720 0.8× 617 1.2× 287 1.3× 106 0.7× 97 1.8k
David Asboe United Kingdom 23 1.1k 0.9× 458 0.5× 731 1.5× 235 1.1× 159 1.0× 67 1.6k
Jason F. Okulicz United States 23 1.3k 1.1× 1.2k 1.2× 707 1.4× 431 2.0× 89 0.5× 137 2.2k
Serge Eholié Ivory Coast 20 948 0.8× 556 0.6× 462 0.9× 200 0.9× 162 1.0× 52 1.2k
Barry S. Zingman United States 20 985 0.8× 438 0.5× 652 1.3× 345 1.6× 123 0.8× 57 1.6k
Fiona Mulcahy Ireland 23 1.1k 0.9× 679 0.7× 428 0.9× 287 1.3× 110 0.7× 48 2.1k
Tammy Meyers South Africa 27 1.4k 1.1× 918 1.0× 495 1.0× 272 1.2× 125 0.8× 52 1.8k
Stephen Raffanti United States 25 1.2k 1.0× 711 0.7× 508 1.0× 673 3.1× 114 0.7× 58 1.9k

Countries citing papers authored by Mauro Zaccarelli

Since Specialization
Citations

This map shows the geographic impact of Mauro Zaccarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Zaccarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Zaccarelli more than expected).

Fields of papers citing papers by Mauro Zaccarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Zaccarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Zaccarelli. The network helps show where Mauro Zaccarelli may publish in the future.

Co-authorship network of co-authors of Mauro Zaccarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Zaccarelli. A scholar is included among the top collaborators of Mauro Zaccarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Zaccarelli. Mauro Zaccarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaccarelli, Mauro, Eugenia Giuliani, Valentina Cafaro, et al.. (2025). Chemsex, sexualized drug use and emotional vulnerability among men who have sex with men (MSM): a one-month survey in a STI/HIV center. BMC Public Health. 25(1). 600–600. 2 indexed citations
2.
Benevolo, Maria, Massimo Giuliani, Paolo Giorgi Rossi, et al.. (2025). High-Resolution Anoscopy Referral Rates Adopting Different Anal Cancer Screening Strategies for Men Who Have Sex with Men. Cancer Prevention Research. 18(5). 291–298. 1 indexed citations
3.
Latini, Alessandra, Maria Gabriella Donà, Massimo Giuliani, et al.. (2021). Short Communication: HIV Viral Load Trends During the Coronavirus Disease 2019 Pandemic in a Reference Center for HIV in Rome, Italy. AIDS Research and Human Retroviruses. 37(8). 624–626. 3 indexed citations
4.
Magri, Francesca, Maria Gabriella Donà, Chiara Panetta, et al.. (2021). Unusual clinical manifestation and challenging serological interpretation of syphilis: insights from a case report. BMC Infectious Diseases. 21(1). 521–521. 6 indexed citations
5.
Minosse, Claudia, Cesare Ernesto Maria Gruber, Martina Rueca, et al.. (2021). Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs. Viruses. 13(6). 1151–1151. 7 indexed citations
6.
Gualano, Gina, Maria Musso, Silvia Mosti, et al.. (2020). Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report. International Journal of Infectious Diseases. 97. 174–176. 22 indexed citations
7.
Bellagamba, Rita, Maria Letizia Giancola, Chiara Tommasi, et al.. (2019). Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment. AIDS. 33(3). 493–502. 8 indexed citations
8.
Saracino, Annalisa, Mauro Zaccarelli, P Lorenzini, et al.. (2018). Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy. BMC Public Health. 18(1). 870–870. 20 indexed citations
9.
Nozza, Silvia, Laura Galli, Andrea Antinori, et al.. (2014). Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study. Clinical Microbiology and Infection. 21(5). 510.e1–510.e9. 24 indexed citations
10.
Sterrantino, Gaetana, Mauro Zaccarelli, Simona Di Giambenedetto, et al.. (2013). HIV Tropism and its Relationship with Transmitted Resistance in Naive Patients. Future Virology. 8(8). 815–820. 1 indexed citations
11.
Sing, Tobias, Valentina Svicher, Maria Mercedes Santoro, et al.. (2009). Dynamics of NRTI Resistance Mutations during Therapy Interruption. AIDS Research and Human Retroviruses. 25(1). 57–64. 12 indexed citations
12.
Trotta, Maria Paola, Adriana Ammassari, Rita Murri, et al.. (2008). Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals. AIDS Patient Care and STDs. 22(4). 291–299. 34 indexed citations
13.
Svicher, Valentina, Stefano Aquaro, Roberta D’Arrigo, et al.. (2008). Specific Enfuvirtide‐Associated Mutational Pathways in HIV‐1 Gp41 Are Significantly Correlated With an Increase in CD4+Cell Count, Despite Virological Failure. The Journal of Infectious Diseases. 197(10). 1408–1418. 35 indexed citations
14.
Manzardo, Christian, Mauro Zaccarelli, Fernando Agüero, Andrea Antinori, & José M. Miró. (2007). Optimal Timing and Best Antiretroviral Regimen in Treatment-naive HIV-Infected Individuals with Advanced Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(Suppl 1). S9–S18. 36 indexed citations
15.
Zaccarelli, Mauro, Carlo Federico Perno, Federica Forbici, et al.. (2004). Q151M‐Mediated Multinucleoside Resistance: Prevalence, Risk Factors, and Response to Salvage Therapy. Clinical Infectious Diseases. 38(3). 433–437. 23 indexed citations
16.
Antinori, Andrea, Mauro Zaccarelli, Antonella Cingolani, et al.. (2002). Cross-Resistance among Nonnucleoside Reverse Transcriptase Inhibitors Limits Recycling Efavirenz after Nevirapine Failure. AIDS Research and Human Retroviruses. 18(12). 835–838. 98 indexed citations
17.
Zaccarelli, Mauro, Patrizio De Longis, Carlo Federico Perno, et al.. (2002). Factors Related to Virologic Failure among HIV-Positive Injecting Drug Users Treated with Combination Antiretroviral Therapy Including Two Nucleoside Reverse Transcriptase Inhibitors and Nevirapine. AIDS Patient Care and STDs. 16(2). 67–73. 24 indexed citations
18.
Pezzotti, Patrizio, Marilena Pappagallo, Andrew Phillips, et al.. (2001). Response to Highly Active Antiretroviral Therapy According to Duration of HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 473–479. 16 indexed citations
19.
Antinori, Andrea, Francesco Baldini, Enrico Girardi, et al.. (2001). Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy. AIDS. 15(12). 1579–1581. 61 indexed citations
20.
Stroffolini, Tommaso, G Manzillo, Elio Manzillo, et al.. (1992). Typhoid fever in the neapolitan area: A case-control study. European Journal of Epidemiology. 8(4). 539–542. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026